NSN 6505-01-252-0802 Parts of Clorazepate Dipotassium Tablets Usp
In the event that you are looking for top quality NSN parts under the NSN 6505-01-252-0802, like 4389-53, NDC00074-4389-53, NDC00228-3067-50, NDC00591-0363-05, NDC00378-0030-05 or others, our team is your finest option. The people at our group can boast of an ISO 9001:2015 accreditation and a FAA AC-0056B certification from the official Federal Aviation Administration group (FAA). Not just that, as a result of our regard to due diligence and quick cutoff times, our customers can depend on us to quickly stock, obtain, deliver and fulfill on whatever parts they are searching for.
For whatever aircraft part of 6505-01-252-0802 you require, you can trust in the professional and expert group at One Click Aviation to have first class determinations for them. Reach us today and see how rapidly we can support you! Our organization offers such advantages like same-day and following day delivery, 100% quality affirmation, every minute of every day client assistance, serious statement in the aeronautics secondary selling and more. Contact us today and see how quickly we can fulfill you Instant RFQ.
Alternative NSN: 6505-01-252-0802 |
Item Name: Clorazepate Dipotassium Tablets Usp |
NIIN: 012520802 |
NCB Code: USA (01) |
Manufacturers: Abbott Laboratories Inc , Actavis Inc , Danbury Pharmacal Inc , Mylan Pharmaceuticals Inc , Rugby Group Inc , Schein Henry Inc , Taro Pharmaceuticals Usa Inc , Warner Lambert Ltd |
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
4389-53 | abbott laboratories inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00074-4389-53 | abbott laboratories inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00228-3067-50 | actavis inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00591-0363-05 | danbury pharmacal inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00378-0030-05 | mylan pharmaceuticals inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00536-4940-05 | rugby group inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00364-2201-05 | schein henry inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC51672-4042-02 | taro pharmaceuticals usa inc | clorazepate dipotassium tablets usp | Avl | RFQ |
NDC00047-0451-30 | warner lambert ltd | clorazepate dipotassium tablets usp | Avl | RFQ |
Characteristics Data of NSN 6505012520802
MRC | Criteria | Characteristic |
---|---|---|
AJCN | PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
FEAT | SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS 3.75MG 500S BT |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
6505-01-252-0802, 6505012520802 Search Related NSN Catalog
Warrantied inventory at competitive prices
Search the world's largest inventory of electronic components by manufacturer, category or part number
We sell only warrantied and traceable parts
All inventory ready to ship from our sellers